Andere Sprachen DIAGNOS Inc.

Aktien

A2PH0N

CA2524423068

ADK

Markt geschlossen - Toronto S.E. Andere Börsenplätze 21:59:59 03.05.2024			% 5 Tage	% 1. Jan.
0,32 ^CAD	+6,67 %		+14,29 %	-20,99 %

16.04.	DIAGNOS Inc. wird die Beantragung der Zulassung für Medizinprodukte bei Health Canada und der US FDA für seine 4 neuen Analysemodule beschleunigen und plant die Zertifizierung nach ISO 27001	CI
02.04.	DIAGNOS Inc. ernennt Philippe Couillard zum Mitglied des Verwaltungsrats	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification	16.04.
DIAGNOS Inc. to Expedite Application for Medical Device License to Health Canada and US FDA Related to its 4 New Analysis Modules, and is Planning ISO 27001 Certification	16.04.
DIAGNOS inc. to Present at the AI & Technology Hybrid Investor Conference April 11th	09.04.
DIAGNOS Announces Grant of Stock Options	03.04.
DIAGNOS Welcomes Dr. Philippe Couillard to its Board of Directors	02.04.
DIAGNOS Inc. Appoints Philippe Couillard to Its Board of Directors	02.04.
Diagnos Raises C$182,000 in the Final Tranche of a Private Placement of Share Units	22.03.
DIAGNOS Announces Closing of Second and Final Tranche of Private Placement	22.03.
DIAGNOS Inc. announced that it has received CAD 0.578 million in funding	22.03.
Diagnos Announces Grant Of Stock Options	04.03.
DIAGNOS Announces Grant of Stock Options	04.03.
DIAGNOS Inc. Appoints Michael Braeuel to Board of Directors	29.02.
DIAGNOS Welcomes Mr. Michael Braeuel to its Board of Directors	29.02.
DIAGNOS Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	28.02.
DIAGNOS Announces Closing Of First Tranche Of Private Placement	27.02.
DIAGNOS Announces Closing of First Tranche of Private Placement	27.02.
DIAGNOS Inc. announced that it expects to receive CAD 1.19244 million in funding	27.02.
Diagnos Announces Variation in One Insider Ownership of Common Shares	23.02.
DIAGNOS recognized as a Top TSX Venture Exchange Company	21.02.
DIAGNOS Appoints New Chief Operating Officer	16.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen DIAGNOS Inc.

Aktien

A2PH0N

CA2524423068

ADK

Andere Sprachen

Filter